SCHEMBL17375690

SCHEMBL17375690

COc1cc2c(cc1OC)-c1cc(OC(C3=CC=CCC3)C3=COC=CO3)cc(=O)n1CC2

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.38
ALDH1A1 P00352 7/20 0.38
HPGD P15428 6/20 0.38
MAPT P10636 6/20 0.38
GLA P06280 1/20 0.38
GPR84 Q9NQS5 5/20 0.36
HSD17B10 Q99714 6/20 0.35
TSHR P16473 5/20 0.35
MAPK1 P28482 5/20 0.35
LMNA P02545 3/20 0.35
KMT2A Q03164 6/20 0.35
POLB P06746 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
PDE4A P27815 2/20 0.34
USP2 O75604 1/20 0.34
GAA P10253 1/20 0.34
RECQL P46063 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
MEN1 O00255 2/20 0.33
L3MBTL1 Q9Y468 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17375766 0.94 KDM4E (0.32) KDM4EALDH1A1HPGDMAPTGLA
SCHEMBL17375788 0.85 KCNK3 (0.35) KDM4EALDH1A1HPGDMAPTGLA
SCHEMBL15826519 0.77 GPR84 (0.47) GPR84
SCHEMBL15825896 0.71 GPR84 (0.35) GPR84
SCHEMBL568334 0.70 MAOB (0.36) KDM4EALDH1A1MAPTKMT2AMEN1
SCHEMBL15826037 0.70 GPR84 (0.37) GPR84
SCHEMBL15825884 0.69 GPR84 (0.42) GPR84
SCHEMBL15822296 0.69 GPR84 (0.48) GPR84
SCHEMBL15825410 0.69 GPR84 (0.53) GPR84
SCHEMBL15824547 0.69 GPR84 (0.50) GPR84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3710004-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR USE IN THE TREATMENT OF FIBROTIC DISEASES Galapagos NV (BE) 2020-09-23 EP claimed
CN-111343986-A Compounds and pharmaceutical compositions thereof for the treatment of fibrotic diseases 加拉帕戈斯股份有限公司 2020-06-26 CN claimed
WO-2015197550-A1 NOVEL DIHYDROPYRIDOISOQUINOLINONES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2015-12-30 WO claimed
EP-3710004-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR USE IN THE TREATMENT OF FIBROTIC DISEASES Galapagos NV (BE) 2020-09-23 EP disclosed
CN-111343986-A Compounds and pharmaceutical compositions thereof for the treatment of fibrotic diseases 加拉帕戈斯股份有限公司 2020-06-26 CN disclosed
WO-2015197550-A1 NOVEL DIHYDROPYRIDOISOQUINOLINONES AND PHARMACEUTICAL COMPOSITIONS THEREOF FOR THE TREATMENT OF INFLAMMATORY DISORDERS GALAPAGOS NV (BE) 2015-12-30 WO disclosed